Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2009-02-05 Regulatory Filings
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2009
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/01/2009, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month. The document is not an announcement of a report but a detailed monthly return. This fits the category of a Regulatory Filing (RNS) as it is a compliance document reporting share capital movements to the exchange, and does not fit other more specific categories like Share Issue/Capital Change (SHA) because it covers a broad range of share capital movements in a regulatory return format.
2009-02-05 English
UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS
Regulatory Filings Classification · 100% confidence The document is an announcement made at the request of the Hong Kong Stock Exchange regarding unusual price and trading volume movements of the company's shares. It states that the board is not aware of any price-sensitive information or negotiations related to acquisitions or disposals. The document is short (1994 characters) and serves as a regulatory disclosure to inform the market about unusual trading activity without providing financial data or detailed reports. It does not contain financial statements, management discussion, or any report content. Therefore, it fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2009-02-04 English
UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS
Regulatory Filings Classification · 95% confidence The document is a short announcement from the board of directors regarding unusual price and trading volume movements of the company's shares. It explicitly states that the board is not aware of any price-sensitive information or negotiations related to acquisitions or disposals. The document is brief (1381 characters) and does not contain any financial data, detailed analysis, or report content. It serves as a regulatory disclosure to comply with stock exchange rules about unusual trading activity. This type of announcement fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2008-12-03 English
MAJOR AND CONNECTED TRANSACTION ACQUISITION OF 51% EQUITY INTEREST AND THE SHAREHOLDER'S LOAN IN OCT INVESTMENTS LIMITED
Capital/Financing Update Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding a major and connected transaction involving the acquisition of a 51% equity interest and a shareholder's loan. It references previous announcements and circulars related to the acquisition and details the terms of the transaction, including cash consideration and issuance of shares. The content focuses on the transaction details and compliance with listing rules, without presenting financial statements or comprehensive financial performance data. This type of document is typical of a Capital/Financing Update, as it provides updates on company fundraising and capital structure changes related to the acquisition and shareholder loan. It is not an annual report, earnings release, or regulatory filing, but a specific transaction announcement.
2008-11-25 English
Interim Report 2008
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data, including turnover, profit margins, expenses, interest expenses, liquidity ratios, gearing ratios, and other financial metrics for the six months ended 30 June 2008. It also includes management discussion and analysis, corporate governance information, directors' interests, and other substantive financial and operational details. The presence of half-year financial data and analysis indicates this is a comprehensive interim financial report rather than a brief announcement or a regulatory filing. The document length is substantial (15,000 characters), and it contains actual financial statements and analysis, not just references or certifications. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2008
2008-08-28 English
2008 INTERIM RESULTS ANNOUNCEMENT
Interim / Quarterly Report Classification · 100% confidence The document is titled '2008 INTERIM RESULTS ANNOUNCEMENT' and contains detailed unaudited consolidated financial statements for the six months ended 30 June 2008, including income statement, balance sheet, notes on accounting policies, tax, dividends, earnings per share, and other financial data. It explicitly states it is an interim financial report prepared under HKAS 34, which governs interim financial reporting. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or a certification. The presence of comprehensive financial statements and notes confirms it is an Interim / Quarterly Report rather than just an earnings release or announcement. Therefore, the appropriate classification is 'IR' for Interim / Quarterly Report. H1 2008
2008-08-21 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.